Bayer AG (FRA:BAYN) has been given a €126.00 ($148.24) price target by equities researchers at Sanford C. Bernstein in a research report issued on Friday. The firm presently has a “buy” rating on the healthcare company’s stock.

Other equities analysts have also recently issued research reports about the company. UBS AG set a €125.00 ($147.06) price target on Bayer AG and gave the company a “buy” rating in a report on Tuesday, June 27th. Deutsche Bank AG set a €124.00 ($145.88) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, June 26th. Citigroup Inc. set a €130.00 ($152.94) price target on Bayer AG and gave the company a “buy” rating in a report on Thursday, June 22nd. Jefferies Group LLC set a €150.00 ($176.47) price target on Bayer AG and gave the company a “buy” rating in a report on Friday, June 16th. Finally, Bank of America Corporation set a €140.00 ($164.71) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, June 12th. Eight equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Bayer AG has a consensus rating of “Buy” and an average price target of €121.55 ($142.99).

Shares of Bayer AG (FRA:BAYN) opened at 117.425 on Friday. The company has a 50-day moving average price of €110.38 and a 200-day moving average price of €111.88. Bayer AG has a 52-week low of €85.72 and a 52-week high of €123.83. The company has a market cap of €102.41 billion and a P/E ratio of 20.312.

ILLEGAL ACTIVITY NOTICE: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/06/bayer-ag-bayn-given-a-126-00-price-target-by-sanford-c-bernstein-analysts.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.